X4 Pharmaceuticals, Inc. (XFOR)
4.14
+0.04
(+0.98%)
USD |
NASDAQ |
Apr 30, 12:56
X4 Pharmaceuticals EPS Diluted (Quarterly) : -0.2164 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Immuneering Corp. | -0.1793 |
| Theravance Biopharma, Inc. | 1.150 |
| vTv Therapeutics, Inc. | -0.5752 |
| Design Therapeutics, Inc. | -0.2871 |
| Tango Therapeutics, Inc. | -0.2945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.92M |
| Revenue (Quarterly) | 2.568M |
| Total Expenses (Quarterly) | 26.49M |
| Enterprise Value | 196.25M |
| Gross Profit Margin (Quarterly) | 84.93% |
| Profit Margin (Quarterly) | -931.7% |
| Earnings Yield | -104.8% |
| Normalized Earnings Yield | -137.17 |